Batch BeaconUK recalls and safety alerts

Medicines defect noticeMHRA

Grepid 75 mg film coated tablets (Kent Pharma Livery) defect notice over a labelling error

Labelling or leaflet errorLow riskClass 4

PHARMATHEN S.A. has informed the MHRA that the outer carton (box) of some batches of Grepid 75mg film coated tablets is missing the medicines legal classification for a Prescription Only Medicine ‘POM.’ This notification contains additional batches impacted by this issue.

Check your product

Only products that match these details are covered. Have your pack in front of you.

43 identifiers listed for this notice.

  • Grepid 75 mg film coated tablets (Kent Pharma Livery) 28

    Batch codePrinted on the pack, often next to the date mark. It may start with L or LOT.
    • 1206250
    • 1206284
    • 1206285
    • 1206235
    • 1206212
    • 1206234
    • 1206041
    • 1206149
    • 1206152
    • 1206211
    • 1208037
    • 1208038
    • 1208123
    • 1208323
    • 1208373
    • 1209215
    • 1209244
    • 1209245
    • 1209246
    • 1209260
    • 1210099
    • 1210103
    • 1210104
    • 1210105
    • 1210106
    • 1304752
    • 1304753
    • 1304862
    • 1304895
    • 1304920
    • 1304943
    Product licenceThe PL number on the carton.
    • PLGB 17277/0398
    ExpiryOn the carton, blister or label.
    • 07/2025
    • 09/2025
    • 10/2025
    • 04/2026
    • 05/2026
    First distributedOn the product, its label or its packaging.
    • 04/08/2022
    • 05/10/2022
    • 07/10/2022
    • 31/10/2022
    • 30/11/2022
    • 13/06/2023

What to do now

A printing or labelling mistake affects some packs of Grepid 75 mg film coated tablets (Kent Pharma Livery).

  1. Do not stop taking a prescribed medicine without advice: missing doses can be more dangerous than the defect.
  2. Compare the batch number printed on the box or label with the batches listed here.
  3. If your pack is affected, take it to your pharmacy or contact the prescriber for a replacement.
  4. Any side effect you think is linked can be reported through the Yellow Card scheme.

Why it matters. Wrong strengths, expiry dates or dosing instructions on a pack can lead to the medicine being taken incorrectly, even though the medicine itself is fine.

Symptoms and when to get help

Look out for

  • a side effect you have not had before
  • your condition not being controlled as well as usual

Get help urgently

  • signs of a severe allergic reaction, such as swelling of the face or throat or difficulty breathing — call 999
  • if you feel unwell and are worried, speak to a pharmacist, your GP or NHS 111

This is general information based on NHS public guidance, not medical advice. In an emergency call 999. For urgent advice use NHS 111 (NHS 24 on 111 in Scotland) or, in Northern Ireland, your GP or out-of-hours service.

Replacements and prescriptions

The MHRA notice tells pharmacies and healthcare professionals what to do. Patients should keep taking their medicine and ask a pharmacist before stopping.

An affected pack bought over the counter can be returned to where you bought it.

From the official notice

Published by the Medicines and Healthcare products Regulatory Agency (EL(24)A/24). Quoted as issued.

Summary

PHARMATHEN S.A. has informed the MHRA that the outer carton (box) of some batches of Grepid 75mg film coated tablets is missing the medicines legal classification for a Prescription Only Medicine ‘POM.’ This notification contains additional batches impacted by this issue.

The risk

MDR number MDR 024-05/23 Company name

Advice for healthcare professionals

Healthcare professionals are advised to exercise caution when handling the listed products and ensure that they are stored accordingly and in line with the guidance for the storage of Prescription Only Medicines (POM). Additionally, healthcare professionals are reminded to only dispense these products when the pharmacy team receives a suitable prescription prescribed by a qualified health professional.

This issue is about missing information on the outer carton (box). The medicine itself is not affected and therefore patients do not need to take any action.

This product will have been prescribed and dispensed by the qualified healthcare professional(s) responsible for your care. If you have any concerns, please speak with your pharmacy team in the first instance. If you have concerns about a medicine you may be using, please contact your healthcare professional.

Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Advice for patients

This issue is about missing information on the outer carton (box). The medicine itself is not affected and therefore patients do not need to take any action.

This product will have been prescribed and dispensed by the qualified healthcare professional(s) responsible for your care. If you have any concerns, please speak with your pharmacy team in the first instance. If you have concerns about a medicine you may be using, please contact your healthcare professional.

Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme .

Open the MHRA notice

Questions

Why has Grepid 75 mg film coated tablets (Kent Pharma Livery) been recalled?

A printing or labelling mistake affects some packs of Grepid 75 mg film coated tablets (Kent Pharma Livery). Wrong strengths, expiry dates or dosing instructions on a pack can lead to the medicine being taken incorrectly, even though the medicine itself is fine.

How do I know if my medicine is affected?

Compare the batch code, product licence, expiry and date code on your pack with the details listed under “Check your product” on this page. Only items that match are covered by the notice.

What should I do now?

Do not stop taking a prescribed medicine without advice: missing doses can be more dangerous than the defect. Compare the batch number printed on the box or label with the batches listed here.

Do I need a new prescription?

The MHRA notice tells pharmacies and healthcare professionals what to do. Patients should keep taking their medicine and ask a pharmacist before stopping. An affected pack bought over the counter can be returned to where you bought it.

Related notices